Clinical use of anti-Müllerian hormone (AMH) determinations in patients with disorders of sex development: importance of sex- and age-specific reference ranges
Publikation: Bidrag til tidsskrift › Review › Forskning
Standard
Clinical use of anti-Müllerian hormone (AMH) determinations in patients with disorders of sex development : importance of sex- and age-specific reference ranges. / Hagen, Casper P; Aksglaede, Lise; Sørensen, Kaspar; Mouritsen, Annette; Juul, Anders.
I: Pediatric Endocrinology Reviews, Bind 9 Suppl 1, 2011, s. 525-8.Publikation: Bidrag til tidsskrift › Review › Forskning
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Clinical use of anti-Müllerian hormone (AMH) determinations in patients with disorders of sex development
T2 - importance of sex- and age-specific reference ranges
AU - Hagen, Casper P
AU - Aksglaede, Lise
AU - Sørensen, Kaspar
AU - Mouritsen, Annette
AU - Juul, Anders
PY - 2011
Y1 - 2011
N2 - Determination of postnatal AMH levels in circulation has been used for decades when evaluating a child with ambiguous genitalia. We describe the age- and gender-specific changes of postnatal AMH serum levels to enable an appropriate clinical use of AMH assessment in pediatric endocrinology. In males, cord blood AMH is measurable at high levels (mean 148 (53-340) pmol/L), whereas AMH is undetectable (54%) or very low (95% CI: <2-16 pmol/L) in female infants. AMH is constant through childhood in both sexes, boys having approximately 35 times higher levels than girls with no overlapping between the sexes until puberty. Ambiguous genitalia due to impaired androgen secretion or action may be a result of various conditions with low, normal or high AMH. Furthermore, low AMH is a marker of premature ovarian failure in Turner Syndrome girls. Measurement of AMH is an important tool in assessing gonadal function in children. In this context, detailed normative data are essential.
AB - Determination of postnatal AMH levels in circulation has been used for decades when evaluating a child with ambiguous genitalia. We describe the age- and gender-specific changes of postnatal AMH serum levels to enable an appropriate clinical use of AMH assessment in pediatric endocrinology. In males, cord blood AMH is measurable at high levels (mean 148 (53-340) pmol/L), whereas AMH is undetectable (54%) or very low (95% CI: <2-16 pmol/L) in female infants. AMH is constant through childhood in both sexes, boys having approximately 35 times higher levels than girls with no overlapping between the sexes until puberty. Ambiguous genitalia due to impaired androgen secretion or action may be a result of various conditions with low, normal or high AMH. Furthermore, low AMH is a marker of premature ovarian failure in Turner Syndrome girls. Measurement of AMH is an important tool in assessing gonadal function in children. In this context, detailed normative data are essential.
M3 - Review
VL - 9 Suppl 1
SP - 525
EP - 528
JO - Pediatric Endocrinology Reviews
JF - Pediatric Endocrinology Reviews
SN - 1565-4753
ER -
ID: 48483965